Literature DB >> 11347739

Diabetes, impaired fasting glucose, and elevated HbA1c in U.S. adolescents: the Third National Health and Nutrition Examination Survey.

A Fagot-Campagna1, J B Saaddine, K M Flegal, G L Beckles.   

Abstract

OBJECTIVE: Using population-based data, we estimated the prevalence of diabetes, impaired fasting glucose, and elevated HbA1c (>6%) levels in U.S. adolescents. RESEARCH DESIGN AND METHODS: The Third National Health and Nutrition Examination Survey (1988-1994) examined a representative sample of the U.S. population, which included 2,867 adolescents aged 12-19 years who had serum glucose measured.
RESULTS: A total of 13 adolescents in the sample were considered to have diabetes; 9 reported using insulin, 2 reported using oral agents only, and 2 did not report any treatment but had high glucose levels (> or = 11.1 mmol/l regardless of length of fast or > or = 7.0 mmol/l after an 8-h fast). Four of these cases (31% of the sample with diabetes) were considered to have type 2 diabetes. The estimated prevalence of diabetes (all types) per 100 adolescents ages 12-19 years was 0.41% (95% confidence interval 0-0.86). The prevalence of impaired fasting glucose (> or = 6.1 mmol/l) among adolescents without diabetes who had fasted for at least 8 h was 1.76% (0.02-3.50). The prevalence of elevated HbA1c (>6%) was 0.39% (0.04-0.74).
CONCLUSIONS: National data reflect the presence of type 2 diabetes in U.S. adolescents, but the survey sample size was not large enough to obtain precise prevalence estimates because of the relatively low prevalence.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11347739     DOI: 10.2337/diacare.24.5.834

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  35 in total

Review 1.  The metabolic syndrome in children and adolescents.

Authors:  Martha L Cruz; Michael I Goran
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

2.  Developing multi-faith chaplaincy.

Authors:  A R Gatrad; E Brown; A Sheikh
Journal:  Arch Dis Child       Date:  2004-06       Impact factor: 3.791

3.  Technology-Assisted Dietary Assessment.

Authors:  Fengqing Zhu; Anand Mariappan; Carol J Boushey; Deb Kerr; Kyle D Lutes; David S Ebert; Edward J Delp
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2008-03-20

4.  Conceptual model for the design of a serious video game promoting self-management among youth with type 1 diabetes.

Authors:  Debbe Thompson; Tom Baranowski; Richard Buday
Journal:  J Diabetes Sci Technol       Date:  2010-05-01

Review 5.  The increasing prevalence of diabetes in pregnancy.

Authors:  Kelly J Hunt; Kelly L Schuller
Journal:  Obstet Gynecol Clin North Am       Date:  2007-06       Impact factor: 2.844

6.  Assessing the risk of impaired glucose metabolism in overweight adolescents in a clinical setting.

Authors:  P A Velasquez-Mieyer; P A Cowan; C P Neira; F Tylavsky
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

7.  Low prevalence of pediatric type 2 diabetes: where's the epidemic?

Authors:  Michael I Goran; Jaimie Davis; Louise Kelly; Gabriel Shaibi; Donna Spruijt-Metz; S Monica Soni; Marc Weigensberg
Journal:  J Pediatr       Date:  2008-06       Impact factor: 4.406

Review 8.  Identification and treatment of metabolic complications in pediatric obesity.

Authors:  Katie Larson Ode; Brigitte I Frohnert; Brandon M Nathan
Journal:  Rev Endocr Metab Disord       Date:  2009-09       Impact factor: 6.514

9.  Self-management in type 2 diabetes: the adolescent perspective.

Authors:  Shelagh A Mulvaney; Eniola Mudasiru; David G Schlundt; Cara L Baughman; Mary Fleming; Ann VanderWoude; William E Russell; Tom A Elasy; Russell Rothman
Journal:  Diabetes Educ       Date:  2008 Jul-Aug       Impact factor: 2.140

10.  Obesity and metabolic syndrome in 7-9 years-old Portuguese schoolchildren.

Authors:  Carla Pedrosa; Bruno Mpm Oliveira; Isabel Albuquerque; Carlos Simões-Pereira; Maria D Vaz-de-Almeida; Flora Correia
Journal:  Diabetol Metab Syndr       Date:  2010-06-10       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.